Virtually all the supply of remdesivir for the next three months has been bought up by the U.S.
The drug, used to treat COVID-19, is made by Gilead. And according to The Guardian newspaper, the U.S. has now bought more than 500,000 doses, which is all of the company’s production for July and 90% of August and September.
“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” said Health and Human Services Secretary Alex Azar. “To the extent possible, we want to ensure that any American patient who needs remdesivir can get it.
Read more at NEWSMAX.